IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Aisling Capital LLC

Q4 2018 Holdings

Filed 2019-02-11 | 9 holdings | $9.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Adma Biologics Inc(ADMA)COM000899104$8.6M3,608,17196.2%
Loxo Oncology IncCOM548862101$285.6K2,038,9203.2%
Aimmune Therapeutics Inc.(AIMT)COM00900T107$47.6K1,990,0000.5%
Transenterix Inc.COM NEW89366M201$5.4K2,389,3520.1%
Cidara Therapeutics Inc.COM171757107$2.4K1,021,1480.0%
Viewray Inc.(VRAYQ)COM92672L107$2.2K363,6400.0%
Chimerix Inc.(CMRXEUR)COM16934W106$1.2K472,9430.0%
Pernix Therapeutics Hldgs inCOM NEW71426V306$88210,0000.0%
Pernix Therapeutics Hldgs IncDBCV 4.250% 4/071426VAK4$16$2,500,0000.0%